MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.antiviral.2020.104868

Медицинская библиотека · Antiviral research · 2020

Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro.

Pan Xiaoyan, Zhou Pengfei, Fan Tiejiong, Wu Yan, Zhang Jing, Shi Xiaoyue, Shang Weijuan, Fang Lijuan, Jiang Xiaming, Shi Jian, Sun Yuan, Zhao Shaojuan, Gong Rui, Chen Ze, Xiao Gengfu

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

COVID-19, which is caused by the emerging human coronavirus SARS-CoV-2, has become a global pandemic that poses a serious threat to human health. To date, no vaccines or specific antiviral drugs have been approved for the treatment of this disease in clinic. Herein, therapeutic antibodies for SARS-CoV-2 were obtained from hyperimmune equine plasma. First, a recombinant SARS-CoV-2 spike protein receptor-binding domain (RBD) was obtained in gram-level quantities through high-cell density fermentation of Chinese hamster ovary cells. Then, the binding of the RBD to the SARS-CoV-2 receptor, human angiotensin-converting enzyme 2, was verified by several biochemical methods. The efficacy of the RBD in triggering antibody response in vivo was subsequently tested in both mice and equines, and the results showed that the RBD triggered high-titer neutralizing antibody production in vivo. Immunoglobulin F(ab')2 fragments were prepared from equine antisera via removal of the Fc region from the immunoglobulins. Finally, a neutralization test with live virus demonstrated that RBD-specific F(ab')2 inhibited SARS-CoV-2 with an EC50 of 0.07 μg/ml and an EC80 of 0.18 μg/ml, showing a potent inhibitory effect on SARS-CoV-2. These results highlight RBD-specific equine immunoglobulin F(ab')2 fragment as a candidate for the treatment of SARS-CoV-2.

Для цитирования: Pan Xiaoyan, Zhou Pengfei, Fan Tiejiong, Wu Yan, Zhang Jing, Shi Xiaoyue, Shang Weijuan, Fang Lijuan, Jiang Xiaming, Shi Jian, Sun Yuan, Zhao Shaojuan, Gong Rui, Chen Ze, Xiao Gengfu. Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro.. Antiviral research. 2020. DOI: 10.1016/j.antiviral.2020.104868.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.